Interdisciplinary Management of Pediatric Obesity: Lessons Learned in the Midsouth

E Thomaseo Burton1,2, Webb A Smith1,2, Idia B Thurston1,2,3

  • 11 Children's Foundation Research Institute, Le Bonheur Children's Hospital, Memphis, TN, USA.

Clinical Pediatrics
|September 15, 2017
PubMed

Insights

This study highlights challenges in pediatric weight management for underserved youth, emphasizing the need to address resource limitations and cultural factors to improve treatment success.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Behavioral Medicine

Background:

  • Alarming pediatric obesity rates in the US Midsouth necessitate targeted interventions.
  • The Healthy Lifestyle Clinic (HLC) was established to manage pediatric obesity and related comorbidities.

Purpose of the Study:

  • To analyze the characteristics and challenges of a diverse pediatric weight management cohort.
  • To provide insights for emerging weight management programs and identify factors influencing treatment attrition.

Main Methods:

  • Retrospective analysis of 380 patients from the HLC with at least 6 months of follow-up.
  • Evaluation of clinical data, including severe obesity and comorbidities like insulin resistance.

Main Results:

  • The cohort was predominantly non-Hispanic Black (67.1%) with severe obesity (zBMI=2.52).
  • High rates of insulin resistance and other comorbidities were observed.
  • Significant challenges were identified in implementing intensive lifestyle changes for families with limited resources.

Conclusions:

  • Interventions must consider socioeconomic and cultural factors for diverse pediatric populations.
  • Further research is needed on environmental and cultural influences to reduce high attrition rates in pediatric obesity treatment.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
312
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
303
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
226
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
321
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503